Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / LifeSci Capital
Entity

LifeSci Capital

Tracked across 4 events · 26 articles · First seen Apr 01, 2026 · Last active Jul 01, 2026

Sentiment
4
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (4)
4 0
Business
Neurogene $125M Public Offering Priced
Impact: LifeSci Capital is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
4 5
Business
Spyre Therapeutics Upsized Public Offering
Impact: LifeSci Capital is acting as a passive bookrunner for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
4 10
Business
Celldex $300M Public Offering Priced
Impact: LifeSci Capital is acting as a co-lead manager for the public offering by Celldex Therapeutics.
Apr 01, 2026 · 6 articles
4 0
Business
Galera and Obsidian Therapeutics Merger
Impact: LifeSci Capital acted as a placement agent in connection with the concurrent private placement financing.
Apr 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track LifeSci Capital live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.